Accéder au contenu
Merck

DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes.

Nucleic acids research (2015-01-02)
Peter Sykora, Magdalena Misiak, Yue Wang, Somnath Ghosh, Giovana S Leandro, Dong Liu, Jane Tian, Beverly A Baptiste, Wei-Na Cong, Boris M Brenerman, Evandro Fang, Kevin G Becker, Royce J Hamilton, Soumya Chigurupati, Yongqing Zhang, Josephine M Egan, Deborah L Croteau, David M Wilson, Mark P Mattson, Vilhelm A Bohr
RÉSUMÉ

We explore the role of DNA damage processing in the progression of cognitive decline by creating a new mouse model. The new model is a cross of a common Alzheimer's disease (AD) mouse (3xTgAD), with a mouse that is heterozygous for the critical DNA base excision repair enzyme, DNA polymerase β. A reduction of this enzyme causes neurodegeneration and aggravates the AD features of the 3xTgAD mouse, inducing neuronal dysfunction, cell death and impairing memory and synaptic plasticity. Transcriptional profiling revealed remarkable similarities in gene expression alterations in brain tissue of human AD patients and 3xTg/Polβ(+/-) mice including abnormalities suggestive of impaired cellular bioenergetics. Our findings demonstrate that a modest decrement in base excision repair capacity can render the brain more vulnerable to AD-related molecular and cellular alterations.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-Beclin-1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution